Yasuhiro Mitsui, Satoru Shinkuma, Yuki Nakamura-Nishimura, Rie Ommori, Kohei Ogawa, Fumi Miyagawa, Yasuko Mori, Mikiko Tohyama, Hideo Asada. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. The journal of allergy and clinical immunology. In practice. 2022. 10. 2. 558-565
R Ommori, Y Nakamura, F Miyagawa, C Shobatake, K Ogawa, F Koyama, M Sho, I Ota, T Kitahara, S Hontsu, et al. Reduced induction of human β-defensins is involved in the pathological mechanism of cutaneous adverse effects caused by epidermal growth factor receptor monoclonal antibodies. Clinical and experimental dermatology. 2020. 45. 8. 1055-1058
Kazuya Miyashita, Fumi Miyagawa, Yuki Nakamura, Rie Ommori, Hiroaki Azukizawa, Hideo Asada. Up-regulation of human herpesvirus 6B-derived microRNAs in the serum of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Acta Dermato-Venereologica. 2018. 98. 6. 612-613
Nakamura-Nishimura Y, Miyagawa F, Miyashita K, Ommori R, Azukizawa H, Asada H. Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome. British Journal of Dermatology. 2018. 178. 6. 1430-1432
Ommori R, Park K, Miyagawa F, Azukizawa H, Kanno M, Asada H. Epidermal growth factor receptor (EGFR) inhibitory monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response. British Journal of Dermatology. 2018. 178. 3. 796-797
K. Miyashita, F. Miyagawa, R. Ommori, Y. Nakamura, H. Azukizawa, H. Asada. HHV-6-derived microRNAs in the serum/PBMC of DIHS/DRESS patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017. 137. 10. S268-S268
R. Ommori, K. Park, F. Miyagawa, H. Azukizawa, H. Asada. EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017. 137. 5. S103-S103